Results 241 to 250 of about 100,010 (342)
Antibody-Drug Conjugates and Beyond: Next-Generation Targeted Therapies for Breast Cancer. [PDF]
Wali AF +12 more
europepmc +1 more source
Nanothermometry in Living Cells: Physical Limits, Conceptual and Material Challenges
Heat and temperature are fundamental to life. When nanothermometers began probing regions as small as a living cell, they triggered controversial claims of large intracellular temperature gradients. We review physical constraints energy‐conservation, entropy production, thermodynamic fluctuations, and molecular dynamics.
Taras Plakhotnik
wiley +1 more source
Recent Technological and Intellectual Property Trends in Antibody–Drug Conjugate Research [PDF]
Youngbo Choi, Y. Choi, Surin Hong
openalex +1 more source
Receptor-mediated gene delivery employing lectin-binding specificity [PDF]
Batra, R. K. +4 more
core
Many cancer nanotherapeutics, while potent, suffer from the inability to escape from the tumor vasculature, especially in the absence of endothelial permeability. In this work, ultrasmall gold nanoclusters could engineer nanomaterials induced endothelial leakiness (NanoEL) and harness strong NIR induced photothermal characteristics to suppress tumor ...
Nengyi Ni +8 more
wiley +1 more source
Clinical applications of antibody-drug conjugates in advanced non-small cell lung cancer. [PDF]
Guo H +6 more
europepmc +1 more source
Tissue Engineered Human Elastic Cartilage From Primary Auricular Chondrocytes for Ear Reconstruction
Despite over three decades of research, no tissue‐engineered solution for auricular reconstruction in microtia patients has reached clinical translation. The key challenge lies in generating functional elastic cartilage ex vivo. Here, we integrate synergistic cell‐biomaterial strategies to engineer auricular grafts with mechanical and histological ...
Philipp Fisch +13 more
wiley +1 more source
Homogeneous antibody-drug conjugates
Despite advances in medical care, cancer remains a major threat to human health. Antibody-drug conjugates (ADCs) are a promising targeted therapy to overcome adverse side effects to normal tissues. In this field, the current challenge is obtaining homogeneous preparations of conjugates, where a defined number of drugs are conjugated to specific ...
Farràs Mañé, Marta|| +10 more
openaire +1 more source

